To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05854381 |
|
Recruitment Status :
Recruiting
First Posted : May 11, 2023
Last Update Posted : December 15, 2023
|
Sponsor:
Vir Biotechnology, Inc.
Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)
HIV Vaccine Trials Network
Information provided by (Responsible Party):
Vir Biotechnology, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | November 2025 |
| Estimated Study Completion Date : | November 2027 |